Based on Tam’s research, we can extrapolate that the most beneficial cannabinoid treatment for those with kidney disease might be cannabinoids that antagonize (block) CB1 receptors while stimulating CB2 receptors.
Read More
Cannabis as a treatment for glaucoma became known in the 1970s due to a few highly publicized case studies like that of Robert Randall, who was the first federally recognized medical marijuana patient with glaucoma in the United States post cannabis prohibition.
Read More
Cachexia, or wasting syndrome, is defined by weight loss, muscle atrophy, fatigue, weakness, and loss of appetite in a person who is not actively trying to lose weight.
Read More
Cannabinoids and the endocannabinoid system (ECS) encompass both ancient and complex aspects of our biology. The endocannabinoid system exists in all vertebrate species, and may have begun evolving as early as 600 million years ago.
Read More
The three most studied conditions linked to Clinical Endocannabinoid Deficiency (CED) are migraines, fibromyalgia, and Irritable Bowel Syndrome.
Read More
There is clear evidence that cannabinoids can be an effective palliative care option for cancer patients.
Read More
It is known that cannabinoids reduce inflammation, and inflammation is often associated with seizures.
Read More
The endocannabinoid system is intimately involved with not only the ability to forget painful, damaging memories, but with fear conditioning as well.
Read More
The endocannabinoid system plays a significant role in the functioning and health of the gastrointestinal system. These findings support the historical use of cannabis to treat digestive disorders dating back centuries.
Read More
THC, CBD and beta caryophyllene (a terpene present in cannabis) have all been shown to reduce pain.
Read More